Filgotinib
GS-US-418-3898
Phase 3 small_molecule completed
Quick answer
Filgotinib for Ulcerative Colitis is a Phase 3 program (small_molecule) at Lakefront Biotherapeutics NV with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed